The TLR2/NF-κB pathway in PAECs likely mediates downstream inflammatory responses induced by reduced compliance of upstream vessels which are less capable of dampening HPF, and thus TLR2 might be a potential target for endothelial inflammation of pulmonary hypertension. The gene discussed is NFKB1; the disease is pulmonary hypertension.